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I thank you and Dr Yang for your encouraging interest in my
manuscript which is entitled “Systematic review: What is the best
ﬁrst-line approach for cesarean section ectopic pregnancy?” [1] As
Dr Yang has most kindly speciﬁed, our manuscript brings forward
interventional methods such as hysteroscopic and laparoscopic hys-
terotomy rather thanmedical methods for the treatment of cesarean
scar pregnancy (CSP). Dr Yang has objected to a result of our manu-
script which argues that uterine artery embolization (UAE) has a low
success rate and a high complication rate as a ﬁrst-line approach for
CSP. Dr Yang has also hypothesized that several factors may be
responsible for this argument about UAE.
The ﬁrst factor is not applying strict criteria for screening the CSP
cases that have been delineated in literature. It is true that a number
of case reports have been included in our systematic review but it
should be understood that CSP is a relatively new medical term
and these case reports are valuable as the ﬁrst scientiﬁc descriptions
for the diagnosis and treatment of CSP. As cesarean deliveries have
gradually increased in number, CSP has become more frequent
and cases of CSP have accumulated to reach a number which is
required publish a case series or clinical study. These publications
have usually focused on the success of a certain treatment method
which has been adopted by a certain study center. We have pre-
sumed that speciﬁcally indicating the success of a certain treatment
method by describing a series of cases and maybe not mentioning
the failure of individual cases would also cause a selection bias.
For this reason individual case reports have been considered as
independent trials for the diagnosis and treatment of CSP prior to
the establishment of management methods for this clinical entity.
Moreover, Dr Yang has contravened our methodology whereby
the efﬁciency of a therapeutic option is assessed by whether this
option leads to a high complication rate and whether the patients
treated with this option need a secondary treatment. It has been
argued that the failure rate of a treatment method may be high
but the hysterectomy rate may be low because treatment methods
may be combined. However, this manuscript seeks the best ﬁrst-
line approach for the treatment of CSP instead of looking for the
best combined treatment. In other words, the aim of our research
has been to deﬁne the treatment method which would achieve
the highest success rate with the lowest complication rate at the
ﬁrst step. The absence of any requirement for any complementary
treatment and the lack of any need for urgent treatment would
surely provide a superior therapeutic option.http://dx.doi.org/10.1016/j.tjog.2016.07.003
1028-4559/Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published
(http://creativecommons.org/licenses/by-nc-nd/4.0/).In literature, most patients treatedwith UAE are cases where the
ﬁrst-line approach of dilation and curettage has been later compli-
cated by excessive uterine bleeding. This has been addressed as the
major reason for the discrepancy between our manuscript and that
of Birch-Petersen et al [2]. Such an occasion has been considered as
a therapeutic failure rather than a successful combined treatment
because of the sudden occurrence of life-threatening hemorrhage.
We think every clinician would regard the value of treating a CSP
without being exposed to the risk of managing an excessive uterine
bleeding.
In addition, there are a number of CSP cases which have also been
complicated by excessive hemorrhage after being primarily treated
with UAE. This failure of UAEmay be attributed to the incompetency
in the interventional skills and techniques. Therefore, I agree with Dr
Yang's comment that the success of a treatment method (especially
an interventional one) depends on the familiarity of the clinician
with this method. It would be prudent to suggest that UAE might
be the most efﬁcient ﬁrst-line treatment in adequately skilled and
experienced hands. At the beginning of our manuscript, we have
chosen the most frequently adopted therapeutic regimens for CSP
because the utilization of recently deﬁned techniques such as trans-
vaginal hysterotomy has not been widespread and standardized
enough to draw a deﬁnite conclusion about its efﬁciency.
In conclusion, we believe that the efﬁciency of a therapeutic op-
tion is based on its association with serious complications (i.e.,
heavy bleeding) and the requirement for urgent complementary
treatment. Any method developed for the treatment of CSP is ex-
pected to annihilate this type of ectopic pregnancy as quickly and
smoothly as possible. Thus, the failure of a treatment method can
be accepted if this method has been unable to dissolve CSP and
also has increased the risk of exposure to heavy hemorrhage and
urgent hysterectomy.
In our research, hysteroscopic resection of CSP and laparoscopic
hysterotomy have emerged as efﬁcient, safe, feasible, and attainable
alternatives for the treatment of CSP.
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